Hyderabad based pharmaceutical company, Gland Pharma targets to raise capital funds worth Rs 6000 – Rs 7000 crores in IPO share launch. In its red herring prospectus filing with SEBI, the company has mentioned that IPO launch will include fresh scrips as well as offer for sale from promoters. Gland Pharma has Chinese parents. Fosun …